Christina Fleitas
Family · Phenix City, ALNPI 1447711627
Payments from drug & device makers
Across 107 payments — averaging $23.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Endologix LLC$1K
- Johnson & Johnson$203
- Medtronic$128
- Shockwave Medical, Inc$122
- Solventum Corporation$114
- Inari Medical, Inc.$104
- plus $609 from 20 others
What the payments were for
- Food & beverage$2,519100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Endologix LLC | 47 | $1,239 |
| Johnson & Johnson | 11 | $203 |
| Medtronic | 6 | $128 |
| Shockwave Medical, Inc | 2 | $122 |
| Solventum Corporation | 5 | $114 |
| Inari Medical, Inc. | 5 | $104 |
| Stryker | 3 | $75 |
| Lemaitre Vascular, Inc. | 4 | $65 |
| Silk Road Medical, Inc. | 3 | $61 |
| Lifenet Health | 3 | $50 |
| Boston Scientific | 2 | $36 |
| E.r. Squibb & Sons, L.L.C. | 2 | $35 |
| Veryan Medical Incorporated | 1 | $30 |
| Smith+Nephew | 1 | $30 |
| Bard Peripheral Vascular, Inc. | 1 | $29 |
| Cvrx, Inc. | 1 | $24 |
| Abbott | 1 | $23 |
| Inspiremd Ltd | 1 | $22 |
| Convatec Inc. | 1 | $20 |
| Terumo Medical Corporation | 1 | $20 |
| Ossur Americas, Inc. | 1 | $20 |
| KCI USA, Inc. | 1 | $18 |
| Baxter Healthcare | 1 | $16 |
| Contego Medical, Inc | 1 | $14 |
| BD | 1 | $13 |
| Flowphysix Inc | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,519 in reported general payments places this provider in the 80th percentile of 3,415 family providers in Alabama.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 81 | $75,594 |
| XareltoRivaroxaban | 33 | $29,640 |
| Enoxaparin Sodium | 14 | $7,577 |
| ClopidogrelClopidogrel Bisulfate | 107 | $1,174 |
| Tramadol Hcl | 18 | $34 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $203 | $29,64033 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,415 family providers in Alabama.
Other family in Phenix City
- Justin WilsonCullman$1.1M
- Leigh Ann ChildressHuntsville$240K
- Molly ReevesAuburn$158K
- Christina CanteyHuntsville$118K
- Leigh LunaMontgomery$69K
- Christopher LovellMobile$64K
- Justin SimpsonTuscaloosa$43K
- Kellyn McMahonBirmingham$39K
- Ashley StinesTuscaloosa$29K
- Brandy YoungMontgomery$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.